Results 141 to 150 of about 921,908 (302)

Factors associated with carrying out activities to stimulate child development in the family context. [PDF]

open access: yesJ Pediatr (Rio J)
Teixeira JH   +7 more
europepmc   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Interplanner variability in carrying out three-dimensional conformal radiation therapy for non-small-cell lung cancer

open access: yes, 2008
Interplanner variability in carrying out three-dimensional conformal radiation therapy for non-small-cell lung ...
C Laferlita (13710724)   +8 more
core  

A Guide to Carrying Out a Phylogenomic Target Sequence Capture Project. [PDF]

open access: yesFront Genet, 2019
Andermann T   +10 more
europepmc   +1 more source

[Carrying out digital work situation analyses for mobile flexible work to ascertain the consequences of mental stress]. [PDF]

open access: yesZentralbl Arbeitsmed Arbeitsschutz Ergon, 2022
Bölsch-Peterka R   +3 more
europepmc   +1 more source

Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis

open access: yesMolecular Oncology, EarlyView.
This schematic outlines the workflow from biomarker identification to duplex MethyLight assay validation for epithelial ovarian cancer diagnosis using cfDNA‐based liquid biopsy. Initial screening of hypermethylated CpG candidates (cg02957270, cg10061138 cg00480298, COL2A1) was performed in tissue using ARMS‐PCR, COBRA, qPCR and image analysis. Selected
Deepa Bisht   +3 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy